CP
SRPT icon

CenterBook Partners’s Sarepta Therapeutics SRPT Stock Holding History

CenterBook Partners’s Portfolio SRPT Stock Details SRPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$832K Buy
+46,293
New +$876K 0.04% 396
2025
Q2 		– Sell
-4,397
Closed -$281K – 593
2025
Q1 		$281K Buy
+4,397
New +$463K 0.02% 456
2023
Q3 		– Sell
-6,054
Closed -$693K – 494
2023
Q2 		$693K Buy
+6,054
New +$781K 0.09% 296

Other funds holding SRPT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

CenterBook Partners's SRPT Position: Q2 2026 in Review

CenterBook Partners opened a new position in Sarepta Therapeutics (SRPT) in Q2 2026: 46,293 shares worth $832K. The stake represents 0.04% of the portfolio and ranks #396 among its holdings. This is a return to the name: CenterBook Partners previously reported a position in SRPT as recently as Q1 2025.

CenterBook Partners first reported a position in SRPT in Q2 2023 and has held it in 3 quarters since. 323 funds tracked by Wall St. Rank hold SRPT as of Q2 2026.

  • CenterBook Partners held 46,293 shares of Sarepta Therapeutics worth $832K as of Q2 2026.
  • Sarepta Therapeutics was a new CenterBook Partners position in Q2 2026.
  • Sarepta Therapeutics made up 0.04% of CenterBook Partners's portfolio in Q2 2026, its #396 holding.
  • CenterBook Partners first reported a position in Sarepta Therapeutics in Q2 2023 and has held it in 3 quarters since.
  • 323 funds tracked by Wall St. Rank held Sarepta Therapeutics as of Q2 2026.

Based on CenterBook Partners's 13F filing for Q2 2026, filed 11 Aug 2026.